JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $895,000 | +627.6% | 107,198 | +793.3% | 0.00% | – |
Q1 2021 | $123,000 | +18.3% | 12,000 | -6.4% | 0.00% | – |
Q3 2020 | $104,000 | -97.4% | 12,824 | -92.8% | 0.00% | -100.0% |
Q1 2018 | $3,968,000 | +71.9% | 177,500 | -2.0% | 0.00% | +100.0% |
Q4 2017 | $2,308,000 | -19.6% | 181,066 | -1.7% | 0.00% | 0.0% |
Q3 2017 | $2,871,000 | +61.2% | 184,243 | +45.2% | 0.00% | 0.0% |
Q2 2017 | $1,781,000 | -49.8% | 126,908 | -21.4% | 0.00% | -50.0% |
Q1 2017 | $3,550,000 | – | 161,474 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |